FDA requests minor labeling changes for NRx Pharmaceuticals' preservative — free ketamine
NRx Pharmaceuticals received an FDA review letter requesting minor labeling changes for its preservative-free ketamine product. The FDA requested sample labeling using the proposed proprietary name, still under review, ahead of the November 10, 2026, review deadline. Final manufacturing process validation runs are unde